Folic Acid EP Impurity B: Chemical Structure, Characterization, and Analytical Significance
Updated: Nov 4
Folic acid, also known as vitamin B9, is an important water-soluble vitamin widely used in pharmaceutical formulations, nutritional supplements, and food fortification products. It plays an essential role in biological processes, including DNA synthesis, amino acid metabolism, and normal cellular development. Maintaining the chemical quality and purity of folic acid is therefore important during pharmaceutical manufacturing and finished-product testing.
During the synthesis, purification, and storage of pharmaceutical ingredients, different related substances and process-associated impurities may require investigation. Folic Acid EP Impurity B is one such identified impurity associated with folic acid. Its chemical identity is 2,5,6-triaminopyrimidin-4(1H)-one, a nitrogen-rich heterocyclic compound.
Understanding the chemical structure, identification characteristics, and analytical significance of this impurity helps pharmaceutical researchers investigate related substances and establish appropriate quality-control procedures. Reference standards of Folic Acid EP Impurity B are useful for analytical method development, impurity identification, and quantitative evaluation.

Chemical Structure and Molecular Characteristics of Folic Acid EP Impurity B
Folic Acid EP Impurity B belongs to the pyrimidinone family of heterocyclic compounds. Its molecular structure contains a six-membered nitrogen-containing aromatic-related heterocyclic framework with three amino substituents and a carbonyl functionality.
The compound is identified chemically as 2,5,6-triaminopyrimidin-4(1H)-one. Its nitrogen-containing ring structure is an important feature for distinguishing it from other folic acid-related substances.
The key chemical identification details are:
Product Name: Folic Acid EP Impurity B
Chemical Name: 2,5,6-Triaminopyrimidin-4(1H)-one
CAS Number: 1004-75-7
Molecular Formula: C₄H₇N₅O
Molecular Weight: 141.13 g/mol
Catalogue Number: CP-F5002
These characteristics provide an initial reference for chemical identification and analytical investigation. It is also important to distinguish the free-base compound from its salt forms. For example, the sulfate form has a different molecular composition and molecular weight, even though it contains the same principal impurity moiety.
Accurate identification of the chemical form is essential when selecting reference materials and interpreting analytical results.
Chemical Characterization and Identification
Chemical characterization is an important part of pharmaceutical impurity evaluation. It helps establish the identity of a compound and provides supporting information for its investigation in pharmaceutical materials.
For Folic Acid EP Impurity B, several analytical techniques can be considered depending on the intended application, available instrumentation, and analytical method requirements.
1. High-Performance Liquid Chromatography (HPLC)
HPLC is widely used in pharmaceutical laboratories for separating and evaluating related substances. It can help assess the chromatographic behaviour of Folic Acid EP Impurity B in comparison with the corresponding reference standard.
Analytical method development may involve evaluating the mobile phase, column chemistry, detection conditions, and sample preparation procedures. The suitability of these parameters should be established experimentally.
2. Liquid Chromatography-Mass Spectrometry (LC-MS)
LC-MS combines chromatographic separation with mass-based detection. It can provide useful information for investigating the molecular mass and identity of an impurity.
For Folic Acid EP Impurity B, mass spectrometric analysis can support identification when used alongside suitable reference materials and other complementary analytical techniques.
3. Nuclear Magnetic Resonance (NMR) Spectroscopy
NMR spectroscopy provides structural information about the molecular environment of hydrogen and carbon atoms.
¹H NMR and ¹³C NMR analysis can help evaluate structural characteristics and support the identification of the pyrimidinone framework. NMR data are particularly useful when establishing the identity of synthesized reference materials.
4. Infrared (IR) Spectroscopy
IR spectroscopy provides information about characteristic molecular vibrations and functional groups.
The amino groups and carbonyl functionality present in Folic Acid EP Impurity B contribute to its infrared absorption characteristics. IR analysis can therefore provide complementary structural evidence when interpreted alongside other analytical results.
No single analytical technique should automatically be considered sufficient for complete identification. Combining chromatographic, spectroscopic, and mass-based techniques can provide a more comprehensive characterization approach.
Formation and Relationship with Folic Acid
Folic acid is a structurally complex molecule containing a pteridine-derived portion, a para-aminobenzoic acid component, and a glutamic acid residue.
The chemical identity of Folic Acid EP Impurity B is particularly relevant because its pyrimidine-based structure is associated with the heterocyclic chemistry involved in folic acid synthesis.
During pharmaceutical process development, intermediates, residual starting materials, and related substances may require investigation to understand their presence in the final material.
However, the actual formation pathway and concentration of Folic Acid EP Impurity B should not be assumed without supporting process or analytical evidence. Its presence and origin need to be evaluated using appropriate manufacturing information and validated analytical procedures.
Understanding the relationship between the impurity and the parent pharmaceutical ingredient helps researchers investigate potential sources and establish suitable impurity-monitoring strategies.
Analytical Significance in Pharmaceutical Quality Control
Impurity monitoring is an important aspect of pharmaceutical quality assurance. Even when a pharmaceutical ingredient meets its primary identity and assay requirements, related substances may still require separate evaluation.
Folic Acid EP Impurity B is relevant to pharmaceutical analytical laboratories for several reasons.
Impurity Identification: A suitable reference standard helps analysts compare chromatographic and spectroscopic characteristics when investigating the presence of this impurity in folic acid samples.
Method Development: Reference materials can support the development and optimization of analytical procedures intended to separate the impurity from the active pharmaceutical ingredient and other related substances.
Quantitative Analysis: An appropriately characterized reference standard can be used to prepare calibration solutions for quantitative analysis, subject to the suitability of the analytical method.
Quality Consistency: Monitoring relevant impurities helps manufacturers evaluate batch-to-batch consistency and investigate changes in the impurity profile during manufacturing and storage.
Regulatory Documentation: Reliable impurity identification and analytical records support pharmaceutical quality documentation and related regulatory activities.
The applicable European Pharmacopoeia monograph and current regulatory requirements should be consulted when establishing impurity specifications and acceptance criteria. Specific limits should not be assumed without reference to the applicable official requirements.
Importance of Folic Acid EP Impurity B Reference Standards
Reference standards are essential analytical materials used to support the identification and evaluation of pharmaceutical impurities.
A suitable Folic Acid EP Impurity B reference standard allows analytical laboratories to compare the behaviour of an unknown sample with a known chemical substance. It can also support analytical method development, system suitability investigations where applicable, and quantitative impurity evaluation.
When selecting an impurity reference standard, pharmaceutical researchers should consider several factors:
Correct chemical identity and CAS number.
Appropriate molecular formula and molecular weight.
Relevant analytical characterization data.
Batch-specific Certificate of Analysis (CoA).
Purity information and applicable test results.
Suitable storage and handling recommendations.
It is particularly important to verify whether the required material is the free-base form or a salt form. Differences in molecular composition can influence sample preparation, concentration calculations, and analytical interpretation.
Folic Acid EP Impurity B Reference Standard from Chemicea
Chemicea Pharmaceuticals Pvt. Ltd. is a chemistry-driven pharmaceutical company specializing in pharmaceutical impurity reference standards, custom synthesis, and analytical solutions.
The company offers reference materials covering various pharmaceutical categories, including process impurities, degradation-related compounds, potential impurities, nitrosamines, metabolites, and other related substances.
Chemicea lists Folic Acid EP Impurity B under the following product identification details:
Product: Folic Acid EP Impurity B
Catalogue Number: CP-F5002
CAS Number: 1004-75-7
Molecular Formula: C₄H₇N₅O
Molecular Weight: 141.13 g/mol
Availability: Custom Synthesis
The product is relevant to pharmaceutical laboratories and researchers working on folic acid impurity profiling, analytical method development, and pharmaceutical quality-control investigations.
For complete product specifications, availability, and ordering information, visit the dedicated product page:
In addition to supplying pharmaceutical impurity reference standards, Chemicea provides custom synthesis capabilities to support research requirements involving specialized pharmaceutical compounds and related substances.
Conclusion
Folic Acid EP Impurity B, chemically identified as 2,5,6-triaminopyrimidin-4(1H)-one, is an important compound for consideration in folic acid-related impurity investigations. Its nitrogen-containing heterocyclic structure provides useful characteristics for chemical identification and analytical characterization.
Techniques such as HPLC, LC-MS, NMR, and IR spectroscopy can contribute to its identification and evaluation when appropriately selected and applied. The availability of suitable reference standards further supports impurity profiling, analytical method development, and pharmaceutical quality-control activities.
For laboratories and pharmaceutical researchers requiring this compound, Chemicea offers Folic Acid EP Impurity B under catalogue number CP-F5002, with custom synthesis availability. Selecting an appropriately characterized reference material helps support reliable analytical investigations and consistent pharmaceutical quality assessment.



Comments